Considerations on COM(2017)132 - EU position at the Eighth Conference of the Parties to the Stockholm Convention on Persistent Organic Pollutants regarding the proposals for amendments of Annexes A and C

Please note

This page contains a limited version of this dossier in the EU Monitor.

 
dossier COM(2017)132 - EU position at the Eighth Conference of the Parties to the Stockholm Convention on Persistent Organic Pollutants regarding ...
document COM(2017)132 EN
date April 25, 2017
 
table>(1)On 14 October 2004, the Stockholm Convention on Persistent Organic Pollutants (‘the Convention’) was approved, on behalf of the European Community, by way of Council Decision 2006/507/EC (1).
(2)The Union has implemented the obligations set out in the Convention in Union law by way of Regulation (EC) No 850/2004 of the European Parliament and of the Council (2).

(3)The Union places strong emphasis on the need for the gradual expansion of Annexes A, B and/or C to the Convention with new substances which fulfil the criteria for persistent organic pollutants (POPs), taking into account the precautionary principle, with a view to meeting the objective of the Convention and the commitment of governments made at the World Summit on Sustainable Development held in Johannesburg in 2002 to minimise the adverse effects of chemicals by 2020.

(4)Pursuant to Article 22 of the Convention, the Conference of the Parties (COP) may adopt decisions amending Annexes A, B and/or C to the Convention. Those decisions enter into force one year from the date of communication by the depositary of an amendment, with the exception of those parties to the Convention (‘the Parties’) that have opted out.

(5)Following a nomination of commercial decabromodiphenyl ether (c-decaBDE) received from Norway in 2013, the Persistent Organic Pollutants Review Committee (POPRC) established under the Convention has concluded its work on c-decaBDE. POPRC has found that c-decaBDE meets the criteria of the Convention for a listing in Annex A thereto. At its eighth meeting, the COP is expected to decide on the inclusion of c-decaBDE in Annex A to the Convention.

(6)The manufacture, placing on the market or use of decabromodiphenyl ether as a substance, as a constituent in other substances, in mixtures and in articles is restricted pursuant to Commission Regulation (EU) 2017/227 (3) establishing entry 67 of Annex XVII to Regulation (EC) No 1907/2006 of the European Parliament and of the Council (4) (REACH) (‘entry 67’). Pursuant to entry 67, the manufacture, placing on the market or use of decabromodiphenyl ether shall only be allowed for a limited time for new aircraft and for spare parts for aircraft, motor vehicles, agricultural and forestry vehicles and certain machinery.

(7)Following a nomination of short-chain chlorinated paraffins (SCCPs) received from the Union in 2006, POPRC has found that SCCPs meet the criteria of the Convention for a listing in Annex A thereto. At its eighth meeting, the COP is expected to decide on the inclusion of SCCPs in Annex A to the Convention.

(8)The production, placing on the market and use of SCCPs is prohibited, with certain exemptions, pursuant to Regulation (EC) No 850/2004, as amended by Commission Regulation (EU) 2015/2030 (5). That amended Regulation also specifies limit values for the presence of SCCPs in other chlorinated paraffin mixtures resulting from the manufacturing process. Since SCCPs are capable of long-range environmental transport, a global phase-out of the use of this substance would be more beneficial to Union citizens than a prohibition under Regulation (EC) No 850/2004 in the Union alone.

(9)Following a nomination of hexachlorobutadiene (HCBD) received from the Union in 2011, POPRC has found that HCBD meets the criteria of the Convention for a listing in Annexes A and C thereto. At its seventh meeting, the COP decided to list HCBD in Annex A to the Convention. However, the COP adopted decision SC-7/11, by which the POPRC was requested to further evaluate HCBD on the basis of newly available information in relation to its listing in Annex C to the Convention and to make a recommendation to the COP on listing HCBD in Annex C for further consideration at its eighth meeting.

(10)The production, placing on the market and use of HCBD is prohibited in the Union pursuant to Regulation (EC) No 850/2004, as amended by Commission Regulation (EU) No 519/2012 (6), but it may be produced unintentionally in some industrial activities. Such activities are covered under Directive 2010/75/EU of the European Parliament and of the Council (7) and require the application of certain emission management measures. Since HCBD is capable of long-range environmental transport, global action on unintentional releases of this substance would be more beneficial to Union citizens than the measures set out in Regulation (EC) No 850/2004 being taken in the Union alone.

(11)Perfluorooctane sulfonic acid (PFOS) and its derivatives are listed in Annex B to the Convention with a number of ‘acceptable purposes’. The COP will be requested to review the continued need of those acceptable purposes. Regulation (EC) No 850/2004 prohibits the production, placing on the market and use of PFOS but exempts certain uses that are still needed in the Union. Consequently, the Union should support the deletion of the acceptable purposes for PFOS and its derivatives that are no longer needed by the Parties, except those for photo-resist and anti-reflective coatings for semi-conductors, as etching agent for compound semi-conductors and ceramic filters and in hard metal plating only in closed-loop systems,